A review of the adverse effects and safety of noradrenergic antidepressants. - Wikidata - wikimedia - TriplyDB

A review of the adverse effects and safety of noradrenergic antidepressants.

A review of the adverse effects and safety of noradrenergic antidepressants.

http://www.wikidata.org/entity/Q38115737

about

Erotic stimulus processing under amisulpride and reboxetine: a placebo-controlled fMRI study in healthy subjects Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Maternal immune activation epigenetically regulates hippocampal serotonin transporter levels.Citalopram-induced hyponatraemia and parkinsonism: potentially fatal side-effects not to be missed.Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study.Pharmacological Management of Anxiety Disorders in the Elderly.Effect of Agomelatine and Fluoxetine on HAM-D Score, Serum Brain-Derived Neurotrophic Factor, and Tumor Necrosis Factor-α Level in Patients With Major Depressive Disorder With Severe Depression.Inhibition of Phosphodiesterase 4 by FCPR03 Alleviates Lipopolysaccharide-Induced Depressive-Like Behaviors in Mice: Involvement of p38 and JNK Signaling Pathways.Electrocardiogram Alterations Associated With Psychotropic Drug Use and CACNA1C Gene Variants in Three Independent Samples.Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review.

P2860

Q30630798-7F57D0B7-A8D0-4362-AE47-2DAA42619411 Q35754726-B0A6B4DF-1E96-4385-A351-3AD91631BD02 Q37486893-250C6499-D214-442C-B6BC-552D196BD499 Q43035180-E19231C6-83CB-43C6-807B-B2447C4B27C3 Q43131864-3CEBAD42-3426-4A55-A6DF-13E137765756 Q47758427-1A8A139D-8A3B-40F5-A436-547D77B0B059 Q47790524-98ACA115-E443-477E-AC00-B7E64F7A7431 Q50117437-B10B2419-14F6-4F50-90FC-AF63055BB179 Q51300430-185D3AE0-5D7D-467C-AFBB-4998BBD717F3 Q55054440-DA7F3EE7-2AB6-4444-82AC-A0AA8FEFE2AB

P2860

A review of the adverse effects and safety of noradrenergic antidepressants.

http://www.wikidata.org/entity/Q38115737

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

A review of the adverse effects and safety of noradrenergic antidepressants.

@en

type

label

A review of the adverse effects and safety of noradrenergic antidepressants.

@en

prefLabel

A review of the adverse effects and safety of noradrenergic antidepressants.

@en

P1433

Q38115737-C9E59BAD-5133-4544-8ACB-E8DCEEC70663

P1476

Q38115737-736A80B1-D5EE-4A3E-A602-C099AE73425F

P2093

Q38115737-EE286AB7-83B1-4C83-98BC-6659970856F5

P2860

Q38115737-03BD4B67-D9CA-45ED-9082-9B3DD857762F

Q38115737-10227228-E869-4608-A67D-EF72AF9251DC

Q38115737-188B9D77-1828-4D71-A6F7-6E3C518EA48D

Q38115737-1E3D8986-564D-4433-9142-478F84906EAC

Q38115737-22E325D0-46FE-453C-8A21-F91B0910F62B

Q38115737-22E3C2AD-1A2A-4E01-9C81-E416AE404FB4

Q38115737-2408C1B9-FBC2-4FA5-8667-5FFA0BCB612F

Q38115737-25274087-AB1F-40C0-9231-BAE964000F6F

Q38115737-2A094E3E-ED60-41BA-84B4-DE45E47D0B47

Q38115737-2DE326D7-80AE-406C-A6C0-94A103D6CAE5

P304

Q38115737-061B8DE5-A34A-4468-A7E3-247504776ACB

P31

Q38115737-30414AFA-23A7-49DC-BA84-2C423200C5EC

P356

Q38115737-80AE96C0-9CFB-426B-B491-E81EA3D9F37E

P407

Q38115737-AAD7FAD0-B2FE-4305-ACA1-6BF76E06BD63

P433

Q38115737-8B3E2402-3389-4725-8D86-10B366816110

P478

Q38115737-C351D30A-A8E6-4DA2-8FD4-C22337B33607

P50

Q38115737-D5309F14-54CE-4F9D-A15F-4305919795AB

P577

Q38115737-EA5645BD-CF01-4F7C-9E37-B965F5AD281F

P698

Q38115737-D46FFD8E-360D-4FF6-8D07-F66213DABC13

P356

0269881113492027

P1433

Journal of Psychopharmacology

P1476

A review of the adverse effects and safety of noradrenergic antidepressants.

@en

P2093

Eromona Whiskey

http://www.w3.org/2001/XMLSchema#string

P2860

The neural control of micturition

Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials

Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

Effects of reboxetine, a selective norepinephrine reuptake inhibitor, on sympathetic and parasympathetic outflow to the heart: preliminary data.

Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.

Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.

Adverse events, toxicity and post-mortem data on duloxetine: case reports and literature survey.

P304

732-739

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0269881113492027

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23784737

http://www.w3.org/2001/XMLSchema#string